Monday
CHMP approves 11 drugs at July meeting
CHMP gives Eli Lilly diabetes drug the nod
Almirall notes ”good traction in Europe” for psoriasis cream Wynzora
Bavarian Nordic granted European approval of monkeypox vaccine
Tuesday
Zealand Pharma hires head of regulatory affairs
FDA clears Ambu’s new bronchoscope generation
EMA appoints new chair of pediatric committee
Wednesday
Janssen nears goal of moving patients to new version of Genmab’s Darzalex
Teva enters billion-dollar settlement in US opioid case
Thursday
Amplifon sales slightly disappoint in Q2
Sanofi lifts forecast as blockbuster eczema drug gains
Coloplast is phasing out natural gas
GN head of media set to join Novo Nordisk
Bavarian Nordic vaccine filling facility approved by US and EU
Friday
Leo Pharma will support abortion-related travel for US employees
Organon enters partnerships with Danish upstart on non-hormonal contraception
Olympus Innovation Fund’s first investment is in endoscopy firm
More from MedWatch
ALK to exit Turkish market: "It's bad business if all we get is peanuts"
A number of conditions made it unfeasible for the Danish allergy firm to do business in Türkiye, says CEO Carsten Hellmann. Under a calculated and ruthless strategy to focus on markets with momentum, efforts in Italy and Spain have also been reduced.
Genmab postpones crucial cancer candidate decision following Abbvie exit
For the rest of 2022, the Danish biotech firm will share all expenses relating to the development of Duohexabody-CD37 with Abbvie, despite the US-based firm’s decision to withdraw from the collaboration in question.
Genmab says new arbitration builds on a straightforward question
”I think this is a much simpler case than the first arbitration,” says Genmab CEO Jan van de Winkel on the new legal suit brought against Janssen, which stems from a fight Genmab has already lost once.
Top news from MedWatch this week
Miss anything?
Analyst: Upgraded ALK sales guidance could still be beaten
Despite an upgrade, ALK may still beat its own sales guidance, one Sydbank analyst predicts.
Scientist Radiochemistry 
Medical Advisor (Metabolism) 
Antibody Engineering Scientist 
Lead Auditor – Senior Quality Assurance Specialist 
Senior Electronics Engineer 
Clinical Project/Trial Manager, Synklino 
Senior Clinical Trial Manager - Black Swans Exist 
Global Quality Director (Business Unit Quality Lead) 
Clinical Biometrics Oversight Lead 
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients 
Clinical Trial Manager - Black Swans Exist 
Director Regulatory Affairs 
GMP Compliance Consultant for Eltronic in Ballerup 
Experienced Biostatistician